dc.creator | Martínez Torres, Alejandra | |
dc.creator | Martínez Gaensly, Miguel | |
dc.date.accessioned | 2019-01-29T17:50:54Z | |
dc.date.available | 2019-01-29T17:50:54Z | |
dc.date.created | 2019-01-29T17:50:54Z | |
dc.date.issued | 2002 | |
dc.identifier | Revista Espanola de Cardiologia, Volumen 55, Issue 6, 2018, Pages 652-656 | |
dc.identifier | 03008932 | |
dc.identifier | 10.1016/S0300-8932(02)76673-6 | |
dc.identifier | https://repositorio.uchile.cl/handle/2250/163459 | |
dc.description.abstract | There is increasing evidence that certain microbial agents may have an etiopathogenic role in the development of atherothrombosis. Helicobacter pylori, a bacterium that causes peptic ulcer disease, has been suggested as one of the microbes involved in the development of atherothrombosis. This hypothesis is based on the following observations: a) a higher prevalence of Helicobacter pylori infection in patients with coronary artery disease, myocardial infarction, or cerebrovascular disease; b) the coincidence of Helicobacter pylori infection and cardiovascular risk factors, such as serum cholesterol and triglyceride concentrations and plasma fibrinogen; c) Helicobacter pylori seropositivity correlates with acute-phase proteins associated with higher risk of coronary disease, such as C-reactive protein, and d) controversial PCR studies indicating the presence of Helicobacter pylori in atheromas. Analysis of the scientific evidence suggests that Helicobacter pylori infection could indirect | |
dc.language | en | |
dc.rights | http://creativecommons.org/licenses/by-nc-nd/3.0/cl/ | |
dc.rights | Attribution-NonCommercial-NoDerivs 3.0 Chile | |
dc.source | Revista Espanola de Cardiologia | |
dc.subject | Atherosclerosis | |
dc.subject | Cardiovascular risk factor | |
dc.subject | Cerebrovascular disease | |
dc.subject | Coronary heart disease | |
dc.subject | Helicobacter pylori | |
dc.title | Helicobacter pylori: A new cardiovascuar risk factor? | |
dc.type | Artículo de revista | |